Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2011
05/18/2011CN102066559A Biotechnological production of cyanophycin dipeptides
05/18/2011CN102066418A Anti-HIV monoclonal antibody
05/18/2011CN102061327A Preparation method of sodium bacillus subtilis lipopeptide
05/18/2011CN102061326A Recycling method of auxiliary fermentation microzyme
05/18/2011CN102061325A Method for preparing cyclodipeptide from Bacillus amyloliquefaciens
05/18/2011CN102061306A Preparation method and application of immunomodulatory peptide
05/18/2011CN102061271A Lactobacillus casei bacteriocin and use thereof in feed
05/18/2011CN102060922A Recombined human estrogen Alpha receptor ligand binding domain protein as well as preparation and application thereof
05/18/2011CN102060914A Lipopeptide compound produced by bacillus marinus B-9987 and preparation and application thereof
05/18/2011CN101613670B Transformant and method for preparing recombined calcitonin-gene-related peptide based on same
05/17/2011US7943745 Anti-CD98 antibody
05/17/2011US7943744 ICAM-1 binding antibodies
05/17/2011US7943742 Anti-αvβ6 antibodies and uses thereof
05/17/2011US7943740 Compositions and methods for the treatment and diagnosis of neoplastic and infectious diseases
05/17/2011US7943738 IL-17 receptor like molecules and uses thereof
05/17/2011US7943737 Bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
05/17/2011US7943736 Bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
05/17/2011US7943735 Bacillus thuringiensis crystal polypetides, polynucleotides, and compositions thereof
05/17/2011US7943734 Bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
05/17/2011US7943728 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation
05/17/2011US7943571 Modified proteins, designer toxins, and methods of making thereof
05/17/2011US7943375 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
05/17/2011US7943364 Coryneform bacterium with reduced glutaminase and enhanced glutamine biosynthetic activity; animal feed and food processing
05/17/2011US7943362 Biosynthesis of phloroglucinol and preparation of 1,3-dihydroxybenzene therefrom
05/17/2011US7943358 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, isolated PEF protein, and methods for purifying and identifying
05/17/2011US7943356 Alcohol dehydrogenase for the stereoselective production of hydroxy compounds
05/17/2011US7943345 Methods, systems and reagents for improved immunodetection
05/17/2011US7943344 Hepatocyte growth factor (HGF) binding proteins
05/17/2011US7943343 Production and use of novel peptide-based agents for use with bi-specific antibodies
05/17/2011US7943341 Expression vector comprising nucleic acid which encodes signal sequence and heterologous protein; for use in transformation and expression in escherichia
05/17/2011US7943340 Fungal dipeptidyl peptidase IV (DPPIV) enzyme for reagent use
05/17/2011US7943339 Isolated nucleic acid molecules from the genome of citrus leprosis virus and uses thereof
05/17/2011US7943300 Method for improved protein expression in bacteria by monitoring and modulating protein folding
05/17/2011US7943134 Compositions and methods for identifying response targets and treating flavivirus infection responses
05/17/2011US7943126 Compositions and methods for treating hypophosphatasia
05/17/2011US7943125 Attenuated gram negative bacteria
05/17/2011CA2415768C Method of producing functional protein domains
05/17/2011CA2401385C Protein matrix materials, devices and methods of making and using thereof
05/17/2011CA2228221C Papillomavirus polyprotein constructs
05/12/2011WO2011057239A2 Secretory protein biomarkers for high efficiency protein expression
05/12/2011WO2011057237A1 Efficient production of peptides
05/12/2011WO2011057134A1 Generation of antigenic virus-like particles through protein-protein linkages
05/12/2011WO2011057064A1 Igf1r inhibitor based treatment of prostate cancer
05/12/2011WO2011056864A1 Methods of generating improved antigen-binding agents using chain shuffling and optionally somatic hypermutation
05/12/2011WO2011056772A1 Engineered anti-tslp antibody
05/12/2011WO2011056644A2 Anti-glp-1r antibodies and their uses
05/12/2011WO2011056561A1 Methods and compositions for the generation and use of conformation-specific antibodies
05/12/2011WO2011056212A1 Libraries of recombinant chimeric proteins
05/12/2011WO2011054255A1 Method for preparing yeast mannose protein product
05/12/2011WO2010121238A9 Methods and kits to predict therapeutic outcome of tyrosine kinase inhibitors
05/12/2011US20110113497 Monoclonal antibodies against gonadotropin-releasing hormone receptor
05/12/2011US20110112990 Efficient Production of Peptides
05/12/2011US20110112283 Rna interference mediating small rna molecules
05/12/2011US20110112179 Cell line, system and method for optical control of secondary messengers
05/12/2011US20110112177 Human G-Protein Coupled Receptor (HETGQ23)
05/12/2011US20110112013 Novel Bacillus thuringiensis Gene with Lepidopteran Activity
05/12/2011US20110111461 Antigen Binding Molecules that Bind EGFR, Vectors Encoding Same, and Uses Thereof
05/12/2011US20110111460 Method for Making Mature Insulin Polypeptides
05/12/2011US20110111459 Compositions and methods for nucleic acid delivery
05/12/2011US20110111458 Industrially useful microorganism
05/12/2011US20110111457 Methods for microbial production of terpenoids
05/12/2011US20110111456 Processing biomass
05/12/2011US20110111455 Polymer-Von Willebrand Factor-Conjugates
05/12/2011US20110111454 ENGINEERED VERSIONS OF CgtB (Beta-1,3 GALACTOSYLTRANSFERASE) ENZYMES, WITH ENHANCED ENZYMATIC PROPERTIES
05/12/2011US20110111408 Methods and composition for secretion of heterologous polypeptides
05/12/2011US20110111406 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
05/12/2011US20110111056 Peptide dicer substrate agents and methods for their specific inhibition of gene expression
05/12/2011US20110110976 Rift valley fever virus-like particles and their use for immunization and as test system
05/12/2011US20110110967 Gas57 mutant antigens and gas57 antibodies
05/12/2011US20110110963 Gene encoding labyrinthin, a marker for cancer
05/12/2011US20110110956 Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins
05/12/2011US20110110938 Compositions and methods for the treatment of immune related diseases
05/12/2011US20110110936 Anti-gcc antibody molecules and related compositions and methods
05/12/2011US20110110852 Multivalent Antibodies and Uses Therefor
05/12/2011US20110108420 Methods for production of proteins
05/12/2011CA2779839A1 T-cell stimulating protein b and methods of use
05/12/2011CA2779384A1 Engineered anti-tslp antibody
05/12/2011CA2778254A1 Secretory protein biomarkers for high efficiency protein expression
05/11/2011EP2320233A1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
05/11/2011EP2319935A2 GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants
05/11/2011EP2319934A2 GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants
05/11/2011EP2319929A1 IL-1 related polypeptides
05/11/2011EP2319928A1 Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
05/11/2011EP2319870A2 Human antibodies that bind human IL-12 and methods for producing
05/11/2011EP2319861A1 A method for identification, isolation and production of antigens to a specific pathogen
05/11/2011EP2319541A1 Factor VII or VIIA-like conjugates
05/11/2011EP2319301A2 Transgenic animals bearing human Ig lambda light chain genes
05/11/2011EP2318524A1 Constructs and methods for the production and secretion of polypeptides
05/11/2011EP2318523A1 Family 6 cellulase with decreased inactivation by lignin
05/11/2011EP1996716B1 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
05/11/2011EP1456398B1 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna
05/11/2011EP1449850B9 Human cdr-grafted antibodies and antibody fragments thereof
05/11/2011EP1381280B1 Viral vectors and their use in therapeutic methods
05/11/2011CN102057054A Human serum albumin linkers and conjugates thereof
05/11/2011CN102057053A Process for the fermentative production of erythropoietin
05/11/2011CN102057044A Composition, method and kit for preparing plasmin
05/11/2011CN102056946A Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
05/11/2011CN102051400A Preparation method of yeast mannose glycoprotein product
05/11/2011CN102051399A Method for extracting blood pressure lowering peptide from tuna
05/11/2011CN102051398A Method for preparing half-fin anchovy antibacterial peptides